AmiClean 7.5 mg (Tablet)
Unit Price: ৳ 0.60 (100's pack: ৳ 60.00)
Medicine Details
Category | Details |
---|---|
Generic | Sodium thiosulfate |
Company | Amico laboratories ltd |
Also available as |
Indications
- Sequential use with sodium nitrite for treatment of acute cyanide poisoning
- Use with caution if the diagnosis of cyanide poisoning is uncertain
Pharmacology
- Sodium thiosulfate acts as an antidote in the treatment of cyanide poisoning
- Acts as a sulphur-donating substrate for the enzyme rhodanese
- Speeds up the conversion of cyanide to thiocyanide
Dosage & Administration
- Adult: To be given after 300 mg of sodium nitrite over 5-20 min
- Child: To be given after 4-10 mg/kg of sodium nitrite (max: 300 mg)
- Methaemoglobin concentration should not exceed 30-40%
- If symptoms of cyanide toxicity recur, the doses of nitrite and thiosulfate may be repeated after 30 min at half the initial doses
Interaction
- Formal drug interaction studies have not been conducted with AmiClean
Side Effects
- Osmotic disturbances
- Oral: catharsis (at high doses)
Pregnancy & Lactation
- Pregnancy Category C
- Sodium Thiosulfate Injection should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus
- Not known whether sodium thiosulfate is excreted in human milk
- Breast-feeding is not a contraindication to its use
- Caution should be exercised following Sodium Thiosulfate Injection administration to a nursing woman
- No data to determine when breastfeeding may be safely restarted following administration of sodium thiosulfate
Precautions & Warnings
- AmiClean drug product may contain trace impurities of sodium sulfite
- Presence of sulfites in AmiClean should not deter administration of the drug for treatment of emergency situations, even if the patient is sulfite-sensitive
Use in Special Populations
- Case reports in medical literature of sodium nitrite administered to pediatric patients with cyanide poisoning
- No clinical studies to evaluate the safety or efficacy of AmiClean in the pediatric population
- AmiClean is known to be substantially excreted by the kidney
- Risk of adverse reactions may be greater in patients with impaired renal function
- Elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function
Overdose Effects
- Limited information about the effects of large doses of AmiClean in humans
- Oral administration of 3 g AmiClean per day for 1-2 weeks resulted in reductions in room air arterial oxygen saturation to as low as 75%
- Rightward shift in the oxygen hemoglobin dissociation curve
- Subjects returned to baseline oxygen saturations 1 week after discontinuation of AmiClean
- Single intravenous administration of 20 mL of 10% AmiClean reportedly did not change oxygen saturations
Therapeutic Class
- Antidote preparations
Storage Conditions
- Store at controlled room temperature between 20°C and 25°C
- Protect from direct light
- Do not freeze